GSK-3 Inhibitors: Anti-Diabetic Treatment Associated with Cardiac Risk?: Editorial to: “The Impact of Chronic Glycogen Synthase Kinase-3 Inhibition on Remodeling of Normal and Pre-Diabetic Rat Hearts.” by Barbara Huisamen et al

GSK-3 Inhibitors: Anti-Diabetic Treatment Associated with Cardiac Risk?: Editorial to: “The Impact of Chronic Glycogen Synthase Kinase-3 Inhibition on Remodeling of Normal and Pre-Diabetic Rat Hearts.” by Barbara Huisamen et al

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cardiovascular drugs and therapy 2016-06, Vol.30 (3), p.233-235
Hauptverfasser: Nabben, Miranda, Neumann, Dietbert
Format: Artikel
Sprache:eng
Schlagworte:
Animals
Cardiology
Editorial
Enzyme Inhibitors
Glycogen Synthase Kinase 3 - antagonists & inhibitors
Heart
Medicine
Medicine & Public Health
Myocardium
Phosphorylation
Rats
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:
ISSN:0920-3206
1573-7241
DOI:10.1007/s10557-016-6669-y